Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Ginkgo and Improved Global Assessment

Doses used in studies

mg/day: 240 (median 240, IQR 240–240) — 1 study

Safety in these studies

Overall tolerabilityNo significant differencep=0.66
The frequency of adverse events was alike in patients treated with EGb 761 and placebo (p=0.66).
from: Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a

1 of 1 paper

Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- 2025-02-03
- Meta-Analysis · n = 782
- The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 26(3)
- - Matthias Riepe
  - Robert Hoerr
  - Sandra Schlaefke
- PubMed: 39895346
- DOI: 10.1080/15622975.2024.2446830
4 Insights on
- Improved Global Assessment
- High evidence
- Clinical
Treatment with 240 mg EGb 761 daily was significantly superior to placebo in global assessment (p = 0.01)
Effect
Beneficial
Effect size
Moderate
Significant
Yes
Dose
240 mg daily